T1	PROC 98 121	terapia de erradicación
#1	AnnotatorNotes T1	C0559761; Helicobacter eradication therapy; Therapeutic or Preventive Procedure
T2	PROC 386 402	práctica clínica
T3	DISO 134 163	infección Helicobacter pylori
T4	PROC 186 242	Estudio randomizado, doble ciego, controlado con placebo
T5	PROC 953 961	tratados
#2	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	PROC 305 328	terapia de erradicación
#3	AnnotatorNotes T6	C0559761; Helicobacter eradication therapy; Therapeutic or Preventive Procedure
T7	DISO 345 378	infección por Helicobacter pylori
#4	AnnotatorNotes T7	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T8	DISO 435 468	Infección por Helicobacter Pylori
#5	AnnotatorNotes T8	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome
T9	PROC 521 529	consulta
#6	AnnotatorNotes T9	C0009818; Consultation; Health Care Activity
T10	PROC 547 558	diagnóstico
#7	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	DISO 571 593	infección por H pylori
T12	PROC 614 635	técnicas diagnósticas
#8	AnnotatorNotes T12	C0430022; diagnostic procedure; Diagnostic Procedure
T13	PROC 647 667	test del aliento C13
#9	AnnotatorNotes T13	C1318610; 13C urea breath test; Laboratory Procedure
T14	PROC 681 687	ureasa
#10	AnnotatorNotes T14	C1504520; Helicobacter pylori urease test; Laboratory Procedure
T15	PROC 692 718	antígeno H pylori en heces
#11	AnnotatorNotes T15	C1294944; Helicobacter pylori antigen assay; Laboratory Procedure (?) | C4700558; Helicobacter pylori antigen in stool; Laboratory Procedure
T16	ANAT 713 718	heces
#12	AnnotatorNotes T16	C0015733; Feces; Body Substance
T17	PROC 910 930	terapia erradicadora
T18	CHEM 966 971	AINES
#13	AnnotatorNotes T18	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T19	CHEM 973 981	aspirina
#14	AnnotatorNotes T19	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T20	CHEM 990 1020	medicamentos antiinflamatorios
#15	AnnotatorNotes T20	C0003209; Anti-Inflammatory Agents; Pharmacologic Substance
T21	PROC 669 679	histología
#16	AnnotatorNotes T21	C0344441; Histology Procedure; Laboratory Procedure
T22	CHEM 1161 1173	antibióticos
#17	AnnotatorNotes T22	C0003232; Antibiotics; Antibiotic
T23	Date 13 17	2017
T24	LIVB 59 91	probiótico Lactobacillus reuteri
#18	AnnotatorNotes T24	C0317625; Lactobacillus reuteri; Bacterium
T26	LIVB 144 163	Helicobacter pylori
#19	AnnotatorNotes T26	C0079488; Helicobacter pylori; Bacterium
T27	LIVB 266 298	probiótico Lactobacillus reuteri
#20	AnnotatorNotes T27	C0317625; Lactobacillus reuteri; Bacterium
T29	LIVB 495 504	Pacientes
#21	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	Age 726 748	entre los 18 a 65 años
T31	LIVB 778 787	Pacientes
#22	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	LIVB 812 823	probióticos
#23	AnnotatorNotes T32	C0525033; Probiotics; Bacterium
T33	Duration 824 833	4 semanas
T34	LIVB 869 878	Pacientes
#24	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 934 942	Paciente
#25	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Frequency 1037 1046	ocasional
T37	Duration 1048 1058	una semana
T38	Duration 1090 1097	crónica
#26	AnnotatorNotes T38	C0205191; chronic; Temporal Concept
T39	Duration 1099 1108	3 semanas
T40	LIVB 1135 1144	Pacientes
#27	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Route 1174 1180	orales
#28	AnnotatorNotes T41	C1527415; Oral Route of Drug administration; Functional Concept
T42	Duration 1182 1193	dos semanas
T43	PHYS 1219 1227	Embarazo
#29	AnnotatorNotes T43	C0032961; Pregnancy; Organism Function
T44	LIVB 359 378	Helicobacter pylori
#30	AnnotatorNotes T44	C0079488; Helicobacter pylori; Bacterium
T45	LIVB 449 468	Helicobacter Pylori
#31	AnnotatorNotes T45	C0079488; Helicobacter pylori; Bacterium
T25	LIVB 585 593	H pylori
T28	LIVB 701 709	H pylori
A1	Status T17 History_of
A2	Status T22 History_of
#32	AnnotatorNotes T4	C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#33	AnnotatorNotes T3	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome 
#34	AnnotatorNotes T11	C0850666; Infection caused by Helicobacter pylori; Disease or Syndrome 
#35	AnnotatorNotes T25	C0079488; Helicobacter pylori; Bacterium
#36	AnnotatorNotes T28	C0079488; Helicobacter pylori; Bacterium
#37	AnnotatorNotes T17	C0559761; Helicobacter eradication therapy; Therapeutic or Preventive Procedure
R1	Used_for Arg1:T24 Arg2:T1	
R2	Causes Arg1:T26 Arg2:T3	
R3	Used_for Arg1:T27 Arg2:T6	
R4	Causes Arg1:T44 Arg2:T7	
T46	Quantifier_or_Qualifier 329 338	cuádruple
R6	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T46	
R7	Causes Arg1:T45 Arg2:T8	
T47	Result_or_Value 559 567	positivo
R9	Has_Result_or_Value Arg1:T10 Arg2:T47	
R10	Experiences Arg1:T29 Arg2:T11	
R11	Causes Arg1:T25 Arg2:T11	
R13	Location_of Arg1:T16 Arg2:T15	
R14	Before Arg1:T12 Arg2:T9	
R15	Before Arg1:T13 Arg2:T10	
R16	Before Arg1:T21 Arg2:T10	
R17	Before Arg1:T14 Arg2:T10	
R18	Before Arg1:T15 Arg2:T10	
T48	PROC 857 864	estudio
#38	AnnotatorNotes T48	C0008976; Clinical Trials; Research Activity
R19	Experiences Arg1:T34 Arg2:T17	
R20	Used_for Arg1:T18 Arg2:T5	
R21	Used_for Arg1:T19 Arg2:T5	
R22	Used_for Arg1:T20 Arg2:T5	
R23	Experiences Arg1:T35 Arg2:T5	
R24	Has_Frequency Arg1:T18 Arg2:T36	
R25	Has_Frequency Arg1:T19 Arg2:T36	
R26	Has_Frequency Arg1:T20 Arg2:T36	
T49	PROC 1069 1076	estudio
#39	AnnotatorNotes T49	C0008976; Clinical Trials; Research Activity
R27	Before Arg1:T5 Arg2:T49	
R28	Has_Duration_or_Interval Arg1:T20 Arg2:T37	
R29	Has_Duration_or_Interval Arg1:T19 Arg2:T37	
R30	Has_Duration_or_Interval Arg1:T18 Arg2:T37	
T50	CONC 1121 1130	inclusión
#40	AnnotatorNotes T50	C1512693; Inclusion; Qualitative Concept
R31	Before Arg1:T5 Arg2:T50	
R32	Has_Duration_or_Interval Arg1:T18 Arg2:T38	
R33	Has_Duration_or_Interval Arg1:T18 Arg2:T39	
R34	Has_Duration_or_Interval Arg1:T19 Arg2:T38	
R35	Has_Duration_or_Interval Arg1:T19 Arg2:T39	
R36	Has_Duration_or_Interval Arg1:T20 Arg2:T38	
R37	Has_Duration_or_Interval Arg1:T20 Arg2:T39	
R38	Experiences Arg1:T40 Arg2:T22	
R39	Has_Route_or_Mode Arg1:T22 Arg2:T41	
R40	Has_Duration_or_Interval Arg1:T22 Arg2:T42	
T51	CONC 1206 1215	inclusión
#41	AnnotatorNotes T51	C1512693; Inclusion; Qualitative Concept
R41	Before Arg1:T22 Arg2:T51	
R42	Before Arg1:T32 Arg2:T48	
R43	Has_Duration_or_Interval Arg1:T32 Arg2:T33	
#42	AnnotatorNotes T47	C1446409; Positive; Finding
R8	Experiences Arg1:T29 Arg2:T12	
R45	Experiences Arg1:T29 Arg2:T13	
R46	Experiences Arg1:T29 Arg2:T21	
R47	Experiences Arg1:T29 Arg2:T14	
R48	Experiences Arg1:T29 Arg2:T15	
R49	Experiences Arg1:T29 Arg2:T9	
R53	Causes Arg1:T28 Arg2:T11	
#43	AnnotatorNotes T46	C0205175; Quadruplicate; Quantitative Concept
A3	Experiencer T29 Patient
A4	Experiencer T31 Patient
A5	Experiencer T34 Patient
A6	Experiencer T35 Patient
A7	Experiencer T40 Patient
